LibertyMark Freedom 10 review

Yes, for a specific buyer. If you're shopping for a principal-protected, index-linked accumulation contract, want more crediting flexibility than a plain fixed annuity, and don't need the money for a full decade, this is a reasonable option to compare against peers. It's not a good fit if you want any form of guaranteed lifetime income (there's no rider for that here), if you might need meaningful liquidity in the next several years, or if you live in one of the roughly 20-plus states where Americo hasn't approved this specific version.

The core appeal is accumulation with downside protection and real choice in how the growth is earned. Someone who likes the idea of index-linked interest but doesn't want to commit to a single strategy can spread premium across four indices and three crediting methods, or fall back to a declared fixed rate. The lack of an explicit base contract fee also matters — you're not paying an annual charge just to hold the contract, only for the optional add-ons you actually elect. For someone planning to leave money alone for 10 years anyway, the longer surrender period isn't necessarily a dealbreaker if the crediting terms are competitive.

I think Freedom 10 is best for someone in their 50s to mid-60s with a genuine 10-year (or longer) time horizon, who is not relying on this money for near-term income and doesn't need a guaranteed income rider because that need is covered elsewhere. It works for both qualified and non-qualified money. It's a weaker fit for anyone closer to needing distributions, anyone who wants income guarantees built into the contract, and — mechanically, not just as a preference — anyone who lives in a state where this product isn't approved, since that rules it out regardless of how competitive the terms look on paper.

You're not buying stock market exposure. You're buying an insurance contract that protects your principal from direct market loss while crediting interest based on formulas tied to index performance — capped, participation-rate, or fixed, depending on what you choose. The "buy-up" options complicate that picture a little: for a 1% annual charge deducted from your account value, you can access a higher cap or participation rate on a given strategy. That charge is guaranteed for the life of the contract and applies whether or not the index actually credits anything that year, so it's a real cost, not a contingent one. Whether the buy-up is worth it depends on the fee-free rate you're giving up versus the higher rate you're buying — that math should be run explicitly before electing it, not assumed.

Freedom 10 credits interest using three methods across four indices — the S&P 500, the S&P 500 IQ Index, the SG Columbia Adaptive Risk Allocation Index, and the SG Lead Asset Select Exposure Rotation Index (SG Laser Index) — plus a Declared Interest Option that functions as a traditional fixed account (currently 4.25% per the brochure snapshot). You can allocate across up to nine crediting options at once: the Declared Interest Option plus as many as eight index options. Depending on the strategy and term, participation rates range roughly 5% to 291% and caps range roughly 1% to 19.90%, with a guaranteed floor of 5% on participation-rate strategies and 1% on cap strategies that can't be reduced below regardless of how rates move. Those are wide ranges because they blend very different strategy types and terms — the specific number that applies to your allocation depends on which combination you pick and when you buy, so treat the brochure snapshot as a point-in-time reference rather than a locked-in figure.

The optional Enhanced Death Benefit rider is the product's second notable feature. For a 0.15% annual charge on the Enhanced Death Benefit base — deducted from account value each contract anniversary and guaranteed never to exceed that rate — it substitutes a benefit equal to premium paid, less prior withdrawals and surrender charges, accumulated at 8.00% simple interest for up to 15 years, in place of the standard death benefit. There's no underwriting and no waiting period, and the rider can be turned off at the client's request. It's available at issue ages 0-75 and isn't offered in California. For someone using this contract partly for legacy planning — passing a larger, more predictable sum to a beneficiary rather than just whatever the account happens to be worth — that rollup is a meaningfully different outcome than the standard death benefit, which is simply the greater of Accumulation Value or Guaranteed Minimum Value.

Ten years is a long commitment, and the schedule front-loads that cost: a 12% surrender charge in year one, stepping down half a point or a full point at a time to 5% in year ten. A market value adjustment also applies, so withdrawals beyond the free amount during the surrender period can be affected by both the charge and prevailing interest rates, in either direction. The standard relief valve is 10% of Accumulation Value penalty-free each year after year one (minimum $500 withdrawal, and Surrender Value must stay above $2,000 afterward). There's also a Nursing Home/Hospital Confinement waiver — not available in Massachusetts — that allows up to 100% of Accumulation Value to come out penalty-free after 90 consecutive days of confinement, provided the request and proof are submitted within 30 days of discharge. That's a genuinely useful backstop, but it's built for a specific circumstance, not general flexibility. This contract should be funded with money you're comfortable not touching for the full decade.

There's no annual contract fee, product fee, M&E charge, or administration charge on the base contract — that's a real point in its favor. The costs that do exist are opt-in: the 0.15% Enhanced Death Benefit rider fee, and the 1% annual buy-up charge on any index option where you elect the higher-rate version. Both are structural trades — you're paying for something specific, not a blanket cost of ownership — but the buy-up fee is worth flagging because it's charged every year regardless of whether that strategy credits any interest, which isn't the case with the fee-free version of the same option. The other tradeoff is the state-approval list: this specific product isn't approved in more than 20 states, which is unusually restrictive for an FIA and worth confirming before you get attached to the terms.

Legal Entity: Americo Financial Life and Annuity Insurance Company

Parent: Americo Life, Inc.

A.M. Best Rating: A